Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular Degeneration
To access this article, please choose from the options below
See accompanying Editorial on page 141.
PII: S0002-9394(06)00332-1
doi:10.1016/j.ajo.2006.02.037
© 2006 Elsevier Inc. All rights reserved.
Refers to article:
- Intravitreal Avastin: The Low Cost Alternative to Lucentis? , 12 May 2006
